Adcentrx Therapeutics' ADRX-0405 granted Chinese regulatory IND clearance to treat late-stage solid tumours

Argo Biopharma to present updated BW-20805 Phase II results at EAACI 2026 Congress

Curasight reports encouraging preliminary Phase 1 data for uTREAT in glioblastoma

Sanofi secures EU approval for subcutaneous Sarclisa with on-body injector

Sciwind Biosciences reports positive study data on ecnoglutide versus semaglutide

OriCell's GPC3 CAR-T Phase II hepatocellular carcinoma trial receives Chinese regulatory clearance

Bayer reports positive Phase III FIND-CKD results for Kerendia in non-diabetic chronic kidney disease

Owkin to build AI agents as part of K Pro collaboration with Sanofi

Gilead and Lakefront complete Ouro Medicines acquisition to expand autoimmune disease pipeline

Kexing Biopharm begins enrolment for Phase I trial of GB10 in China

Lupeng Pharmaceutical's rocbrutinib receives Chinese approval to treat R/R mantle cell lymphoma

Pharming secures FDA acceptance of Joenja filing for children with APDS

UCB and Biogen present Phase 3 data highlighting potential of dapirolizumab pegol in lupus treatment

Persist AI partners with Microsize and Micromacinazione to launch drug formulation platform

RedHill Biopharma advancing opaganib options for Ebola outbreak